CD56 NK Cell Tumor Test | Lahalak Platform
An advanced diagnostic suite for detecting rare and aggressive tumors in the nervous and endocrine systems, aiding precise classification and guiding targeted therapy.
Scientific name: Immunohistochemistry (IHC): CD56 (Natural Killer Cells)
This diagnostic package, based on immunohistochemistry, includes the testing of a range of markers to diagnose a variety of tumors. The package primarily includes testing for CD56 (NCAM - Neural Cell Adhesion Molecule), a membrane marker expressed by natural killer (NK) cells, certain T cells, neurons, and neuroendocrine tumor cells, as well as ess...
Included Services
- CD56 is tested for the primary marker to identify tumors of NK-cell or neuroendocrine origin.
- Complementary markers were examined to confirm the diagnosis: CD3, and a neuroendocrine marker (Synaptophysin or Chromogranin A).
- Testing for the epithelial marker (cytokeratin) to help rule out traditional epithelial cancers.
- Consult a pathologist specializing in hematological or neuroendocrine tumors for interpretation of the overall results.
Medical Service Information
Conditions & Notices
- It requires the submission of a complete tissue block (paraffin block) of the tumor biopsy specimen (from sinuses, skin, lung, etc.).
- It is necessary to attach the initial pathology report with an accurate description of the specimen and its anatomical location.
- The patient does not need to fast, as the sample is tissue-based.
- Due to the diversity and specialization of tumors, the completion time may range from 7 to 14 working days.